Anaesthetic management of the hypotonic uterus
Authors:
P. Nosková 1,2; J. Bláha 1,2; R. Klozová 1,3; D. Seidlová 1,4; P. Štourač 1,5; A. Pařízek 6
Authors place of work:
Sekce porodnické anestezie a analgezie ČSARIM
1; Klinika anesteziologie, resuscitace a intenzivni mediciny, 1. LF UK a VFN v Praze
2; Klinika anesteziologie a resuscitace, II. LF UK a FN Motol
3; II. anesteziologicko-resuscitační oddělení FN Brno
4; Klinika dětské anesteziologie a resuscitace, LF MU a FN Brno
5; Gynekologicko-porodnická klinika, 1. LF UK a VFN v Praze
6
Published in the journal:
Anest. intenziv. Med., 26, 2015, č. 3, s. 145-149
Category:
Anaesthesiology - Review Article
Hypotonie/atonie děložní je nejčastější příčinou peripartálního život ohrožujícího krvácení. Cílem článku je podat informace o současných možnostech léčby této závažné komplikace. Podrobněji jsou rozebrány farmakologické vlastnosti uterotonik, jejichž nesprávné podání může paradoxně vést ke zhoršení kritického stavu. Současně je zdůrazněna nutnost mezioborové spolupráce při řešení hypotonie/atonie děložní.
Summary
Uterine hypotony/atony is the most common cause of life-threatening peripartum bleeding. The article presents information on the current treatment approaches for this serious complication. The pharmacological properties of the uterotonic agents are discussed in detail. Their incorrect administration may paradoxically lead to a deterioration in the critical condition. We also emphasize the need for concurrent interdisciplinary co-operation in the management of uterine hypotony/atony.
Keywords:
uterine atony – uterotonic agents – intrauterine balloon tamponade – surgical interventions – hysterectomy
Zdroje
1. Kvasnička, J., Balík, M., Binder, T., Blatný, J., Bláha, J., Cvachovec, K., Černý, V., Dulíček, P., Feyereisl, J., Hájek, Z.,Janků, P., Malý, J., Měchurová, A., Pařízek, A., Penka, M., Procházka, M., Roztočil, A., Řeháček, V., Seidlová, D., Ševčík, P.,Valenta, J., Ventruba, P. Peripartální život ohrožující krvácení – mezioborové konsenzuální stanovisko. Vnitř. Lék., 2012, 58, 9, p. 661–664.
2. Balík, M., Binder, T., Blatný, J., Bláha, J., Cvachovec, K., Černý, V., Dulíček, P., Feyereisl, J., Hájek, Z., Janků, P., Kvasnička, J., Malý, J., Měchurová, A., Pařízek, A., Penka, M., Procházka, M., Roztočil, A., Řeháček, V., Seidlová, D., Ševčík, P., Valenta, J., Ventruba P. Peripartální život ohrožující krvácení. Čes. Gynek., 2013, 78, Supplementum, p. 38–40.
3. www.csarim.cz/Public/csim/PERIPARTALNI_ZIVOT_OHROZUJICI_KRVACENI_MEZIOBOROVE_KONSENSUALNI_STANOVISKO_2011.pdf
4. Gard, J. W., Alexander, J. M., Bawdon, R. E., Albrecht, J. T. Oxytocin preparation stability in several common obstetric intravenous solutions. American Journal of Obstetrics and Gynecology, 2002, 186, 3, p. 496–498.
5. Stephens, L. C., Bruessel, T. Systematic review of oxytocin dosing at caesarean section. Anaesthesia and intensive care, 2012, 40, 2, p. 247–252.
6. Petersson, M. Cardiovascular effects of oxytocin. Progress in brain research, 2002, 139, p. 281–288.
7. Gutkowska, J., Jankowski, M. Oxytocin revisited: its role in cardiovascular regulation. Journal of Neuroendocrinology, 2012, 24, 4, p. 599–608.
8. Mukaddam-Daher, S., Yin, Y. L., Roy, J., Gutkowska, J., Cardinal, R. Negative inotropic and chronotropic effects of oxytocin. Hypertension, 2001, 38, 2, p. 292–296.
9. Jonsson, M., Hanson, U., Lidell, C., Norden-Lindeberg, S. ST depression at caesarean section and the relation to oxytocin dose. A randomised controlled trial. BJOG : an international journal of obstetrics and gynaecology, 2010, 117, 1, p. 76–83.
10. Svanstrom, M. C., Biber, B., Hanes, M., Johansson, G., Naslund, U., Balfors, E. M. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section. British Journal of Anaesthesia, 2008, 100, 5, p. 683–689.
11. Archer, T. L., Knape, K., Liles, D., Wheeler, A. S., Carter, B. The hemodynamics of oxytocin and other vasoactive agents during neuraxial anesthesia for cesarean delivery: findings in six cases. International Journal of Obstetric Anesthesia, 2008, 17, 3, p. 247–254.
12. Jackson, K. W., Jr., Allbert, J. R., Schemmer, G. K., Elliot, M., Humphrey, A., Taylor, J. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. American Journal of Obstetrics and Gynecology, 2001, 185, 4, p. 873–877.
13. Davies, G. A., Tessier, J. L., Woodman, M. C., Lipson, A., Hahn, P. M. Maternal hemodynamics after oxytocin bolus compared with infusion in the third stage of labor: a randomized controlled trial. Obstetrics and Gynecology, 2005, 105, 2, p. 294–299.
14. Nordstrom, L., Fogelstam, K., Fridman, G., Larsson, A., Rydhstroem, H. Routine oxytocin in the third stage of labour: a placebo controlled randomised trial. British Journal of Obstetrics and Gynaecology, 1997, 104, 7, p. 781–786.
15. Thomas, J. S., Koh, S. H., Cooper, G. M. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section. British Journal of Anaesthesia, 2007, 98, 1, p. 116–119.
16. Butwick, A. J., Coleman, L., Cohen, S. E., Riley, E. T., Carvalho, B. Minimum effective bolus dose of oxytocin during elective Caesarean delivery. British Journal of Anaesthesia, 2010, 104, 3, p. 338–343.
17. Su, L. L., Chong, Y. S., Samuel, M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst. Rev., 2012, 4, CD005457.
18. Dansereau, J., Joshi, A. K., Helewa, M. E., Doran, T. A., Lange, I. R., Luther, E. R., Farine, D., Schulz, M. L., Horbay, G. L., Griffin, P. et al. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section. American Journal of Obstetrics and Gynecology, 1999, 180, 3 Pt, 1, p. 670–676.
19. McDonald, S., Abbott, J. M., Higgins, S. P. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst. Rev., 2004, 1, CD000201.
20. Štourač, P., Bláha, J., Nosková, P., Klozová, R., Seidlová, D., Jarkovský, J., Zelinková, H. Časná poporodní anestezie z pohledu studie OBAAMA-CZ – prospektivní observační studie. Anest. intenziv. Med., 2014, 25, 5, p. 341–347.
21. Stourac, P., Blaha, J., Klozova, R., Noskova, P., Seidlova, D., Brozova, L., Jarkovsky, J. Anesthesia for Cesarean Delivery in the Czech Republic: A 2011 National Survey. Anesth. Analg., 2014, Dec 16. [Epub ahead of print].
22. Larsen, R. Anestezie. Praha: Grada, 2004, p. 933.
23. Larsen, R. Anestezie. Praha: Grada, 2004, p. 934.
Štítky
Anaesthesiology, Resuscitation and Inten Intensive Care Medicine Gynaecology and obstetrics HaematologyČlánok vyšiel v časopise
Anaesthesiology and Intensive Care Medicine
2015 Číslo 3
- What FVIII Levels Are Ideal for Preventing Bleeding in Hemophilia A?
- Cost Effectiveness of FVIII Substitution Versus Non-Factor Therapy for Hemophilia A
- Administration of aPCC as a Prevention of Bleeding After Major Cardiac Surgical Procedures
- Efficacy and Safety of Two Pharmacokinetically-Driven Prophylactic Regimens in People with Hemophilia A
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
Najčítanejšie v tomto čísle
- Anaesthetic management of the hypotonic uterus
- PRES (Posterior reversibleencefalopathy syndrome) in a pre-eclamptic woman with twin pregnancy – case report
- Biological treatment and the risk of perioperative complications
- Preoperative examination of the autonomic nervous system by measurement of the heart rate variability for prediction of the perioperative course